Viridian Therapeutics, Inc.\DE (VRDN) Gains from Investment Securities: 2014-2024
Historic Gains from Investment Securities for Viridian Therapeutics, Inc.\DE (VRDN) over the last 4 years, with Dec 2024 value amounting to $945,000.
- Viridian Therapeutics, Inc.\DE's Gains from Investment Securities was N/A to $945,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $465,000, marking a year-over-year change of. This contributed to the annual value of $496,000 for FY2024, which is 1700.00% up from last year.
- Per Viridian Therapeutics, Inc.\DE's latest filing, its Gains from Investment Securities stood at $945,000 for Q4 2024, which was up 310.47% from -$449,000 recorded in Q3 2024.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Gains from Investment Securities ranged from a high of $945,000 in Q4 2024 and a low of -$449,000 during Q3 2024.
- Its 2-year average for Gains from Investment Securities is $116,250, with a median of -$15,500 in 2023.
- As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Gains from Investment Securities tumbled by 325.00% in 2020, and later spiked by 105.81% in 2021.
- Over the past 4 years, Viridian Therapeutics, Inc.\DE's Gains from Investment Securities (Quarterly) stood at -$1,000 in 2020, then tumbled by 100.00% to -$2,000 in 2021, then reached -$1,000 in 2023, then reached $945,000 in 2024.
- Its Gains from Investment Securities stands at $945,000 for Q4 2024, versus -$449,000 for Q3 2024 and -$1,000 for Q2 2023.